These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 5451178)

  • 61. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 62. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract]   [Full Text] [Related]  

  • 63. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 64. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA; Utkin VV; Korotaev GA; Golitsina LV
    Probl Tuberk; 1967; 45(5):29-33. PubMed ID: 5617941
    [No Abstract]   [Full Text] [Related]  

  • 65. [Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance].
    Shmelev NA; Shabalova LN; Kolosovskaia VP
    Antibiotiki; 1975 Feb; 20(2):174-80. PubMed ID: 1091207
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
    Tanaka E
    Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140
    [No Abstract]   [Full Text] [Related]  

  • 68. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 69. [CHEMO-ANTIBIOTIC THERAPY IN PULMONARY TUBERCULOSIS].
    RUSSO V
    Rass Int Clin Ter; 1963 Sep; 43():1009-13. PubMed ID: 14091636
    [No Abstract]   [Full Text] [Related]  

  • 70. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract]   [Full Text] [Related]  

  • 72. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
    Malinowska B; Pawlak F
    Gruzlica; 1970; 38(6):531-5. PubMed ID: 4317029
    [No Abstract]   [Full Text] [Related]  

  • 73. [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis].
    Aspevik E
    Tidsskr Nor Laegeforen; 1967 Mar; 87(6):548-54. PubMed ID: 6047184
    [No Abstract]   [Full Text] [Related]  

  • 74. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [CLINICAL AND BACTERIOLOGICAL FINDINGS ON THE USE OF MORPHAZINAMIDE IN THE TREATMENT OF CHRONIC TUBERCULOSIS].
    CERCHIAI E; BELLUOMINI R
    G Ital Chemioter; 1963; 10():74-8. PubMed ID: 14079396
    [No Abstract]   [Full Text] [Related]  

  • 76. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract]   [Full Text] [Related]  

  • 77. [Capreomycin and ethambutol].
    Wilson TM
    Gruzlica; 1968 Oct; 36(10):1053-7. PubMed ID: 5710088
    [No Abstract]   [Full Text] [Related]  

  • 78. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 79. [TREATMENT OF CHRONIC DESTRUCTIVE TUBERCULOSIS OF THE LUNGS WITH TUBERCULOSTATIC PREPARATIONS OF THE 2D SERIES].
    SHMELEV NA; KAMINSKAIA AA; KARACHUNSKII MA; STEPANIAN ES; GOLITSYNA LV; KOROTAEV GA; UTKIN VV
    Probl Tuberk; 1963; 41():16-23. PubMed ID: 14108756
    [No Abstract]   [Full Text] [Related]  

  • 80. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.